Browse our anti-FIGF (Figf) Antibodies

Full name:
anti-C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) Antibodies (Figf)
On are 167 C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) (Figf) Antibodies from 25 different suppliers available. Additionally we are shipping FIGF Kits (55) and FIGF Proteins (36) and many more products for this protein. A total of 268 FIGF products are currently listed.
AI325264, FIGF, Vegf-d, Vegfd

Most Popular Reactivities for anti-FIGF (Figf) Antibodies

Select your species and application

anti-Mouse (Murine) FIGF Antibodies:

anti-Rat (Rattus) FIGF Antibodies:

anti-Human FIGF Antibodies:

All available anti-FIGF Antibodies

Go to our pre-filtered search.

Top referenced anti-FIGF Antibodies

  1. Human Monoclonal FIGF Primary Antibody for WB - ABIN387760 : Romero, Friel, Velez Edwards, Kusanovic, Hassan, Mazaki-Tovi, Vaisbuch, Kim, Erez, Chaiworapongsa, Pearce, Bartlett, Salisbury, Anant, Vovis, Lee, Gomez, Behnke, Oyarzun, Tromp, Williams, Menon: A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). in American journal of obstetrics and gynecology 2010 (PubMed)
    Show all 6 references for 387760

  2. Human Polyclonal FIGF Primary Antibody for EIA, IHC (p) - ABIN358813 : Orlandini, Semboloni, Oliviero: Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. in The Journal of biological chemistry 2003 (PubMed)
    Show all 3 references for 358813

  3. Human Polyclonal FIGF Primary Antibody for EIA, WB - ABIN115681 : Kirkin, Mazitschek, Krishnan, Steffen, Waltenberger, Pepper, Giannis, Sleeman: Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. in European journal of biochemistry / FEBS 2001 (PubMed)

  4. Human Monoclonal FIGF Primary Antibody for IHC (p), IHC - ABIN258825 : Schimanski, Schlaegel, Jordan, Moehler, Sgourakis, Drescher, Galle, Lang, Gockel: VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery. in World journal of surgery 2011 (PubMed)

More Antibodies against FIGF Interaction Partners

Zebrafish C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) (Figf) interaction partners

  1. vegfc (show VEGFC Antibodies) and vegfd cooperatively control lymphangiogenesis throughout the embryo, including during the formation of the trunk lymphatic vasculature. Interestingly, we find that vegfd and vegfc (show VEGFC Antibodies) also redundantly drive artery hyperbranching phenotypes observed upon depletion of Flt1 (show FLT1 Antibodies) or Dll4 (show DLL4 Antibodies).

  2. Vegfd can compensate for loss of Vegfc (show VEGFC Antibodies) in zebrafish facial lymphatic sprouting.

  3. VEGFD-mediated pathologies include or involve an underlying dysregulation of SOXF-mediated transcriptional networks.

  4. Our studies therefore identified the first non-mammalian VEGF-D and established its in vivo role for vascular system development during vertebrate embryogenesis and provided an alternative animal model to further reveal functions of VEGF-D.

Mouse (Murine) C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) (Figf) interaction partners

  1. lymphangiogenesis is regulated by two distinct proteolytic mechanisms of ligand activation: one in which VEGFC (show VEGFC Antibodies) activation by ADAMTS3 (show Adamts2 Antibodies) and CCBE1 (show CCBE1 Antibodies) spatially and temporally patterns developing lymphatics, and one in which VEGFD activation by a distinct proteolytic mechanism may be stimulated during inflammatory lymphatic growth

  2. This study uncovers a reciprocal relationship between dendrite geometry, the ability to generate nuclear calcium transients in response to synaptic inputs, and the subsequent induction of expression of plasticity-related and dendritic structure-preserving genes. Insufficient nuclear calcium signaling in CA1 (show CA1 Antibodies) hippocampal neurons and, consequently, reduced expression of the nuclear calcium target gene VEGFD.

  3. Overexpression of VEGFD causes lymphatic hyperplasia in lung, kidney, and brown adipose tissue. Overexpression of VEGFD in white adipose tissue causes a de novo lymphatic network.

  4. Vegf-d promotes oedema in response to hyperoxia in mice and support the hypothesis that VEGF-D signalling promotes vascular leak in human hyperoxic acute lung injury (HALI).

  5. VEGF-D may be beneficial in early-stage tumors since it suppresses the pro-tumorigenic inflammation, while at later stages VEGF-D-induced tumor lymphatics provide a route for metastasis.

  6. These results suggest that lymph node lymphangiogenesis occurs before metastasis in OSCC. VEGF-A (show VEGFA Antibodies) and VEGF-D play critical roles in this process.

  7. Results provided evidence that IL-7 (show IL7 Antibodies)/IL-7R induce VEGF-D upregulation and promote lymphangiogenesis via c-Fos/c-Jun (show JUN Antibodies) pathway in lung cancer.

  8. Epidermal keratinocyte proliferation in vitro was not affected by VEGF-C (show VEGFC Antibodies) or VEGF-D.

  9. Neutrophils contribute to lymphangiogenesis primarily by modulating VEGF-A (show VEGFA Antibodies) bioavailability and bioactivity and, to a lesser extent, secreting VEGF-D. Neutrophils increased VEGF-A (show VEGFA Antibodies) bioavailability and bioactivity via the secretion of MMP9 (show MMP9 Antibodies) and heparanase (show HPSE Antibodies).

  10. Vegf-d deficiency alters the caliber of initial lymphatics in the dermis leading to reduced functional capacity.

Human C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D) (Figf) interaction partners

  1. High VEGFD expression is associated with lymphangioleiomyomatosis.

  2. Data show that VEGF-C (show VEGFC Antibodies), VEGF-D, and VEGFR-3 (show FLT4 Antibodies) were expressed in a substantial percentage of breast carcinomas.

  3. High VEGFD expression is associated with angiogenesis and lymphangiogenesis.

  4. VEGF-D and its receptors were co-localized on blood vessels in clinical samples of human lungs exposed to hyperoxia; hence, VEGF-D may act directly on blood vessels to promote fluid leak.

  5. VEGF-D-enhanced metastasis was evidently reversed by MP. MP significantly reduced the invasion of VEGFD-SK cells, tumor volume, lymphatic metastasis rates and lymphatic vessel density compared with control groups

  6. Sulf2 (show SULF2 Antibodies) facilitated lymphangiogenesis in breast cancer cells by regulating VEGF-D and that the AKT1related signaling pathway was involved.

  7. Data indicate that vascular endothelial growth factor D (VEGF-D) was the best indicator of metastasis and vascular endothelial growth factors and receptor-3 (VEGFR-3 (show FLT4 Antibodies)) may help to determine the prognosis and management of colorectal cancer (CRC (show CALR Antibodies)).

  8. Taken together, our data suggest that TNF-alpha (show TNF Antibodies) can promote lymphangiogenesis and lymphatic metastasis of GBC through the ERK1/2 (show MAPK1/3 Antibodies)/AP-1 (show FOSB Antibodies)/VEGF-D pathway.

  9. VEGF-D may play an important role in the process of lymphatic metastasis of epithelial ovarian cancer

  10. CCL21 (show CCL21 Antibodies)/CCR7 (show CCR7 Antibodies) induce VEGF-D up-regulation and promote lymphangiogenesis via ERK (show EPHB2 Antibodies)/Akt (show AKT1 Antibodies) pathway in lung cancer.

FIGF (Figf) Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus.

Alternative names and synonyms associated with FIGF (Figf)

  • c-fos induced growth factor (vascular endothelial growth factor D) (FIGF) antibody
  • c-fos induced growth factor (figf) antibody
  • c-fos induced growth factor (vascular endothelial growth factor D) (figf) antibody
  • Vascular endothelial growth factor D (vegfd) antibody
  • c-fos induced growth factor (Figf) antibody
  • AI325264 antibody
  • FIGF antibody
  • Vegf-d antibody
  • Vegfd antibody

Protein level used designations for Figf

c-fos induced growth factor (vascular endothelial growth factor D) , vascular endothelial growth factor D , vascular enthelial growth factor D , vegf d , vegf-d , Vascular endothelial growth factor D , c-fos-induced growth factor

712654 Macaca mulatta
100050877 Equus caballus
100601827 Nomascus leucogenys
678512 Danio rerio
100144690 Xenopus (Silurana) tropicalis
100158352 Xenopus laevis
465508 Pan troglodytes
493703 Felis catus
100195607 Salmo salar
14205 Mus musculus
360457 Rattus norvegicus
2277 Homo sapiens
286799 Bos taurus
100338090 Oryctolagus cuniculus
100155670 Sus scrofa
491749 Canis lupus familiaris
395255 Gallus gallus
101102873 Ovis aries
Selected quality suppliers for anti-FIGF (Figf) Antibodies
Did you look for something else?